In vivo MRI visualization of different cell populations labeled with PARACEST agents

Magnetic Resonance in Medicine

Volumn 69, Issue 6, 2013, Pages 1703-1711

  Ferrauto, Giuseppe ^a   Castelli, Daniela Delli ^a   Terreno, Enzo ^a   Aime, Silvio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

cell labeling; cell tracking; lanthanides; MRI; PARACEST agents

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CHEMICAL STABILITY; EUROPIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; PARAMAGNETISM; RARE EARTH ELEMENTS; YTTERBIUM COMPOUNDS;

CELL LABELING; CELL TRACKING; CHEMICAL EXCHANGE SATURATION TRANSFER; CLINICAL TRANSLATION; MRI CONTRAST AGENTS; PARACEST; PARAMAGNETIC CHEMICAL-EXCHANGE-SATURATION- TRANSFERS; SELECTIVE IRRADIATION;

CELLS;

CONTRAST MEDIUM; GADOTERIDOL; PARAMAGNETIC CHEMICAL EXCHANGE SATURATION TRANSFER AGENT; UNCLASSIFIED DRUG; YTTERBIUM;

ANIMAL CELL; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; ELECTROPORATION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MACROPHAGE; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84878114462     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24411     Document Type: Article

References (29)

1. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, Himmelreich U,. Cell tracking using magnetic resonance imaging. J Physiol 2007; 584 (Part 1): 25-30.
2. Himmelreich U, Dresselaers T,. Cell labeling and tracking for experimental models using magnetic resonance imaging. Methods 2009; 48: 112-124.
3. Weissleder R, Pitter MJ,. Imaging in the era of molecular oncology. Nature 2008; 452|3: 580-589.
4. Berman SM, Walczak P, Bulte JW,. MRI of transplanted neural stem cells. Methods Mol Biol 2011; 711: 435-449
5. Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, de Vries IJ, Figdor CG,. Imaging of cellular therapies. Adv Drug Deliv Rev 2010; 62: 1080-1093.
6. Modo M, Hoehn M, Bulte JW,. Cellular MR imaging. Mol Imaging 2005; 4: 143-164.
7. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN,. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16: 4712-4727.
8. Barnett BP, Ruiz-Cabello J, Hota P, Ouwerkerk R, Shamblott MJ, Lauzon C, Walczak P, Gilson WD, Chacko VP, Kraitchman DL, Arepally A, Bulte JW,. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging 2011; 6: 251-259.
9. Ahrens ET, Flores R, Xu H, Morel PA,. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005; 23: 983-987.
10. Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C,. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med 2011; 65: 1144-1153.
11. Ward KM, Aletras AH, Balaban RS,. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143: 79-87.
12. Terreno E, Castelli DD, Aime S,. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imaging 2010; 5: 78-98.
13. Zhang S, Merritt M, Woessner DE, Lenkinski RE, Sherry AD,. PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res 2003; 36: 783-790.
14. Sherry AD, Woods M,. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 2008; 10: 391-411.
15. Van Zijl PC, Yadav NN,. Chemical exchange saturation transfer (CEST): what is in a name and what isn't?. Magn Reson Med 2011; 65: 927-948.
16. Liu G, Bulte JW, Gilad AA,. CEST MRI reporter genes. Methods Mol Biol 2011; 711: 271-280.
17. McMahon MT, Gilad AA, DeLiso MA, Berman SM, Bulte JW, van Zijl PC,. New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med 2008; 60: 803-812.
18. Gilad AA, McMahon MT, Walczak P, Winnard PT, Jr, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC,. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007; 25: 217-219.
19. Aime S, Carrera C, Delli Castelli D, Geninatti Crich S, Terreno E,. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew Chem Int Ed Engl 2005; 44: 1813-1815.
20. Delli Castelli D, Terreno E, Aime S,. Yb(III)-HPDO3A: a dual pH- and temperature-responsive CEST agent. Angew Chem Int Ed Engl 2011; 50: 1798-1800.
21. Terreno E, Geninatti Crich E, Belfiore E, Biancone L, Cabella C, Esposito G, Manazza AD, Aime S,. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn Res Med 2006; 55: 491-497.
22. Lewis CE, Pollard JW,. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605-612.
23. Shih YY, Hsu YH, Duong TQ, Lin SS, Chow KP, Chang C,. Longitudinal study of tumor-associated macrophages during tumor expansion using MRI. NMR Biomed 2011; 24: 1353-1360.
24. Corsi DM, Iglesias CP, van Bekkum H, Peters JA,. Determination of paramagnetic lanthanide(III) concentrations from bulk magnetic susceptibility shifts in NMR spectra. Magn Res Chem 2001; 11: 723-726.
25. Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S,. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 2008; 4: 136-149.
26. Terreno E, Stancanello J, Longo D, Castelli DD, Milone L, Sanders HM, Kok MB, Uggeri F, Aime S,. Methods for an improved detection of the MRI-CEST effect. Contrast Media Mol Imaging 2008; 5: 237-247.
27. Smith W,. Responses of laboratory animals to some injectable anesthetics. Lab Anim 1993; 27: 30-39.
28. Flecknell PA,. Laboratory animal anesthesia. London: Academic Press; 1996. pp 159-224.
29. Erhardt W, Hebestedt A, Aschenbrenner G, Pichotka B, Blumel G,. A comparative study with various anesthetics in mice. Res Exp Med 1984; 184: 159-169.